Regulation
Missouri Surveys Marijuana Researchers on Licensing Barriers

Key PointsMissouri requires separate department approval for each research study even after a…
View more
- Missouri requires separate department approval for each research study even after a facility license is granted.
- Research licensees cannot sell final marijuana product to consumers patients or caregivers under the rule.
- Human-subject studies need dual IRB approval plus a physician and an experienced principal investigator.
Missouri’s Division of Cannabis Regulation asked prospective marijuana researchers on November 19, 2026, to describe the studies they are considering and the barriers they expect in obtaining or using a research license. The outreach is directed at individuals, educational institutions, healthcare organizations and other entities as Missouri’s marijuana research facility rule approaches its November 30, 2026, effective date.
The online survey asks respondents to describe their organizations and the individuals involved in research, specific types of studies of interest or being planned, anticipated licensing barriers, and readiness to apply and begin studies. Regulators also scheduled an informational webinar for December 7, 2026, at 2 p.m., with registration required, to review the license framework, application process and regulatory requirements.
Separate Approvals for Facilities and Studies
Under the final marijuana research facility rule, a research facility license will be valid for three years. Holding that license will not authorize operations: the licensee must pass a commencement inspection and receive department approval for its research study before beginning marijuana research. Each proposed study requires its own review, so facility licensure is not blanket approval for a research program.
The rule sets a $500 nonrefundable facility application fee and requires ownership information, a proposed location and local zoning materials, blueprints identifying rooms and security areas, any cultivation practices, attestations covering fingerprint-based background checks and disqualifying felonies, and a written plan for documenting access to the facility and marijuana. When researchers are part of a larger entity with unrelated activities, such as a university, the affiliated entity conducting the marijuana research must be the applicant.
Each study application requires another $250 nonrefundable fee, an abstract, a research question, a rationale and a protocol. Depending on the proposal, submissions also address expected sample sizes and marijuana testing methods, the amount of marijuana to be cultivated, whether human or animal subjects are involved, and any plan to transfer research-produced seeds or clones to a cultivation facility.
Research Product Faces Separate Limits
Licensed facilities may acquire marijuana product from cultivation or manufacturing facilities, cultivate and manufacture marijuana, store product on-site and transfer it to or from testing or other research facilities. They may also sell or donate product to another research facility.
The license does not permit sales of final marijuana product to consumers, qualifying patients or primary caregivers. Transfers to cultivation, manufacturing or dispensary facilities require department approval. Research-produced seeds and clones can move to a cultivation facility only when that transfer is included in a department-approved study. The restrictions make study approval central not only to the research protocol but also to how marijuana and research-produced plants move between license types.
Testing and Subject Safeguards
Before any marijuana product can be administered to human or animal subjects, it must pass mandatory testing by a licensed marijuana testing facility, and the research licensee must receive verification of that result. Research licensees may not perform mandatory testing themselves.
Human-subject studies must be approved or determined exempt by both the department’s institutional review board (IRB) and an IRB of record registered and in good standing with the federal Office for Human Research Protections. Each study requires monitoring by a licensed physician in good standing and a principal investigator with at least five years of human-subject research experience.
Facilities conducting animal studies must hold a U.S. Department of Agriculture animal welfare research registration and obtain approval from an Institutional Animal Care and Use Committee registered and in good standing with the National Institutes of Health Office of Laboratory Animal Welfare. They also require a licensed veterinarian in good standing to monitor subjects and a principal investigator with at least five years of animal-subject research experience.
The outreach gives regulators an opportunity to identify practical obstacles before implementation. The central implementation question is whether interested organizations can turn early research concepts into applications that satisfy facility readiness, study-specific review and the protections attached to the subjects and marijuana involved.












